학술논문
THE BIOBEHÇET'S TRIAL: OPTIMAL UTILISATION OF BIOLOGIC DRUGS IN BEHÇET'S DISEASE: A RANDOMISED CONTROLLED TRIAL OF INFLIXIMAB VS ALPHA INTERFERON, WITH GENOTYPING AND METABOLOMIC PROFILING, TOWARDS A STRATIFIED MEDICINES APPROACH TO TREATMENT.
Document Type
Article
Author
Source
Annals of the Rheumatic Diseases; 2023 Supplement, Vol. 82, p337-337, 1/2p
Subject
Language
ISSN
00034967